Newborn screening for phenylketonuria: Machine learning vs clinicians

Wei Hsin Chen*, Han Ping Chen, Yi Ju Tseng, Kai Ping Hsu, Sheau Ling Hsieh, Yin Hsiu Chien, Wuh Liang Hwu, Feipei Lai

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

4 Scopus citations

Abstract

The metabolic disorders may hinder an infant's normal physical or mental development during the neonatal period. The metabolic diseases can be treated by effective therapies if the diseases are discovered in the early stages. Therefore, newborn screening program is essential to prevent neonatal from these damages. In the paper, a support vector machine (SVM) based algorithm is introduced in place of cut-off value decision to evaluate the analyte elevation raw data associated with Phenylketonuria. The data were obtained from tandem mass spectrometry (MS/MS) for newborns. In addition, a combined feature selection mechanism is proposed to compare with the cut-off scheme. By adapting the mechanism, the number of suspected cases is reduced substantially; it also handles the medical resources effectively and efficiently.

Original languageEnglish
Title of host publicationProceedings of the 2012 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining, ASONAM 2012
Pages798-803
Number of pages6
DOIs
StatePublished - 2012
Externally publishedYes
Event2012 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining, ASONAM 2012 - Istanbul, Turkey
Duration: 26 08 201229 08 2012

Publication series

NameProceedings of the 2012 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining, ASONAM 2012

Conference

Conference2012 IEEE/ACM International Conference on Advances in Social Networks Analysis and Mining, ASONAM 2012
Country/TerritoryTurkey
CityIstanbul
Period26/08/1229/08/12

Keywords

  • Newborn screening
  • Support vector machine
  • Tandem mass spectrometry

Fingerprint

Dive into the research topics of 'Newborn screening for phenylketonuria: Machine learning vs clinicians'. Together they form a unique fingerprint.

Cite this